◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Cardiol Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00 0.00
Selling General And Administration 5.4M 4.9M 4.6M 5.8M 10.2M
General And Administrative Expense 5.4M 4.9M 4.6M 5.8M 10.2M
Research And Development 4.8M 2.7M 3.8M 4.2M 3.8M
Depreciation And Amortization In Income Statement 25,551 25,470 24,986 -- 201,090
Operating Expense 10.2M 7.7M 8.4M 10.0M 14.1M
Operating Income -10.2M -7.7M -8.4M -10.0M -14.1M
EBIT -10.2M -7.7M -8.4M -10.0M -14.1M
Interest Income 122,256 180,667 248,269 306,775 201,864
Interest Income Non Operating 122,256 180,667 248,269 306,775 201,864
Net Interest Income 122,256 180,667 248,269 306,775 201,864
Other Income Expense 93,563 -858,880 -106,859 1.5M 1.2M
Other Non Operating Income Expenses -- -- -- 0.00 --
Gain On Sale Of Security 93,563 -858,880 -106,859 1.5M 1.2M
Pretax Income -10.0M -8.4M -8.3M -8.2M -12.7M
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -10.0M -8.4M -8.3M -8.2M -12.7M
Net Income From Continuing Operation Net Minority Interest -10.0M -8.4M -8.3M -8.2M -12.7M
Net Income Including Noncontrolling Interests -10.0M -8.4M -8.3M -8.2M -12.7M
Net Income Common Stockholders -10.0M -8.4M -8.3M -8.2M -12.7M
Net Income -10.0M -8.4M -8.3M -8.2M -12.7M
EBITDA -10.2M -7.7M -8.4M -9.9M -13.9M
Normalized EBITDA -10.2M -6.8M -8.3M -11.4M -15.1M
Reconciled Depreciation 25,551 25,470 24,986 48,493 201,090
Basic EPS -0.12 -0.10 -0.10 -- -0.18
Diluted EPS -0.12 -0.10 -0.10 -- -0.18
Basic Average Shares 84.7M 82.7M 82.6M -- 69.8M
Diluted Average Shares 84.7M 82.7M 82.6M -- 69.8M
Total Unusual Items 93,563 -858,880 -106,859 1.5M 1.2M
Total Unusual Items Excluding Goodwill 93,563 -858,880 -106,859 1.5M 1.2M
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00
Normalized Income -10.1M -7.5M -8.2M -9.7M -13.9M
Amortization 0.00 0.00 0.00 -- 168,136
Amortization Of Intangibles Income Statement 0.00 0.00 0.00 -- 168,136
Depreciation Amortization Depletion Income Statement 25,551 25,470 24,986 -- 201,090
Depreciation Income Statement 25,551 25,470 24,986 -- 32,954
Diluted NI Availto Com Stockholders -10.0M -8.4M -8.3M -8.2M -12.7M
Net Income Continuous Operations -10.0M -8.4M -8.3M -8.2M -12.7M
Net Non Operating Interest Income Expense 122,256 180,667 248,269 306,775 201,864
Other Gand A 2.1M 2.7M 3.8M 5.8M 2.7M
Salaries And Wages 3.3M 2.2M 838,346 -- 7.4M
Total Expenses 10.2M 7.7M 8.4M 10.0M 14.1M
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 11.6M 18.2M 23.3M 30.6M 15.9M
Cash Cash Equivalents And Short Term Investments 11.6M 18.2M 23.3M 30.6M 15.9M
Accounts Receivable 37,494 58,921 75,960 100,366 57,079
Receivables 195,880 279,887 346,690 361,621 266,706
Prepaid Assets 988,532 1.3M 1.6M 726,509 1.1M
Current Assets 12.8M 19.8M 25.3M 31.7M 17.3M
Gross PPE 989,647 986,629 980,190 968,251 1.0M
Accumulated Depreciation -848,666 -823,115 -797,645 -772,659 -771,021
Net PPE 140,981 163,514 182,545 195,592 237,926
Goodwill And Other Intangible Assets -- -- -- 0.00 0.00
Other Intangible Assets -- -- -- -- --
Total Non Current Assets 140,981 163,514 182,545 195,592 237,926
Total Assets 12.9M 19.9M 25.5M 31.9M 17.5M
Current Debt And Capital Lease Obligation 36,925 35,556 34,252 33,009 31,785
Payables And Accrued Expenses 3.3M 8.0M 7.7M 7.0M 6.9M
Other Current Liabilities -- -- -- -- 3,647
Current Liabilities 3.3M 8.0M 7.8M 7.0M 7.0M
Long Term Debt And Capital Lease Obligation 97,274 106,998 116,408 125,523 134,199
Long Term Capital Lease Obligation 97,274 106,998 116,408 125,523 134,199
Total Non Current Liabilities Net Minority Interest 97,274 106,998 116,408 125,523 134,199
Total Liabilities Net Minority Interest 3.4M 8.1M 7.9M 7.1M 7.1M
Common Stock 187.4M 179.5M 179.3M 179.3M 154.6M
Capital Stock 187.4M 179.5M 179.3M 179.3M 154.6M
Additional Paid In Capital 28.1M 28.2M 25.8M 24.6M 27.5M
Retained Earnings -205.9M -195.9M -187.5M -179.3M -171.7M
Common Stock Equity 9.6M 11.8M 17.6M 24.7M 10.4M
Stockholders Equity 9.6M 11.8M 17.6M 24.7M 10.4M
Total Equity Gross Minority Interest 9.6M 11.8M 17.6M 24.7M 10.4M
Total Capitalization 9.6M 11.8M 17.6M 24.7M 10.4M
Net Tangible Assets 9.6M 11.8M 17.6M 24.7M 10.4M
Tangible Book Value 9.6M 11.8M 17.6M 24.7M 10.4M
Working Capital 9.5M 11.8M 17.5M 24.7M 10.3M
Invested Capital 9.6M 11.8M 17.6M 24.7M 10.4M
Total Debt 134,199 142,554 150,660 158,532 165,984
Share Issued 87.5M 82.7M 82.6M 82.6M 70.2M
Ordinary Shares Number 87.5M 82.7M 82.6M 82.6M 70.2M
Capital Lease Obligations 134,199 142,554 150,660 158,532 165,984
Current Capital Lease Obligation 36,925 35,556 34,252 33,009 31,785
Leases 237,248 237,248 237,248 237,248 237,248
Machinery Furniture Equipment 238,207 235,189 228,750 216,811 210,652
Other Properties 514,192 514,192 514,192 514,192 561,047
Other Receivables 158,386 220,966 270,730 261,255 209,627
Properties 0.00 0.00 0.00 0.00 0.00
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -6.9M -4.6M -7.2M -5.6M -7.8M
Cash Flow From Continuing Operating Activities -6.9M -4.6M -7.2M -5.6M -7.8M
Depreciation And Amortization 25,551 25,470 24,986 48,493 201,090
Depreciation Amortization Depletion 25,551 25,470 24,986 48,493 201,090
Stock Based Compensation 4.0M 2.5M 1.1M 3.1M 8.4M
Change In Working Capital -622,146 671,355 -151,824 990,411 -2.7M
Changes In Account Receivables 21,427 17,039 24,406 -43,287 36,572
Change In Receivables 84,007 66,803 14,931 -94,915 -24,282
Change In Payables And Accrued Expense -1.0M 270,839 739,695 681,840 -3.1M
Other Non Cash Items 5,489 5,738 5,972 6,392 6,326
Capital Expenditure -3,018 -6,439 -11,939 -6,159 -7,871
Purchase Of PPE -3,018 -6,439 -11,939 -6,159 -7,871
Net PPE Purchase And Sale -3,018 -6,439 -11,939 -6,159 -7,871
Investing Cash Flow -3,018 -6,439 -11,939 -6,159 -7,871
Cash Flow From Continuing Investing Activities -3,018 -6,439 -11,939 -6,159 -7,871
Repayment Of Debt -13,844 -13,844 -13,844 -13,844 -4,615
Net Issuance Payments Of Debt -13,844 -13,844 -13,844 -13,844 -4,615
Financing Cash Flow -13,844 20,416 -13,844 18.7M -4,615
Cash Flow From Continuing Financing Activities -13,844 20,416 -13,844 18.7M -4,615
Effect Of Exchange Rate Changes 369,229 -561,052 -107,778 1.6M -354,655
Changes In Cash -6.9M -4.5M -7.2M 13.1M -7.8M
Beginning Cash Position 18.2M 23.3M 30.6M 15.9M 24.0M
End Cash Position 11.6M 18.2M 23.3M 30.6M 15.9M
Free Cash Flow -6.9M -4.6M -7.2M -5.6M -7.8M
Amortization Cash Flow 0.00 0.00 0.00 0.00 168,136
Amortization Of Intangibles 0.00 0.00 0.00 0.00 168,136
Change In Prepaid Assets 310,714 333,713 -906,450 403,486 487,859
Depreciation 25,551 25,470 24,986 48,493 32,954
Gain Loss On Investment Securities -- -- -- -3,647 -1.4M
Long Term Debt Payments -13,844 -13,844 -13,844 -13,844 -4,615
Net Foreign Currency Exchange Gain Loss -369,229 561,052 107,778 -1.6M 354,655
Net Income From Continuing Operations -10.0M -8.4M -8.3M -8.2M -12.7M
Net Long Term Debt Issuance -13,844 -13,844 -13,844 -13,844 -4,615
Operating Gains Losses -369,229 561,052 107,778 -1.6M -997,430
Proceeds From Stock Option Exercised 0.00 34,260 0.00 0.00 0.00
NEWS
Loading news...
TRENDING
Loading...